The world for the past few months has been speaking a lot on COVID vaccines and how it is our way out of this pandemic. But it will be a long time before the entire world is vaccinated. So what do we do to prevent severe symptoms or hospitalisation till then?
A new anti-viral pill for COVID-19 treatment from pharma giants Merck and Pfizer Inc, aims to reduce the risk of hospitalisation and even death. These new drugs – Merck’s Molnupiravir and Pfizer’s Paxlovid – are currently in their clinical trials but have shown promising results, especially the latter, which claims to reduce the risk of hospitalisation by 89 percent.